Milestone Scientific Inc.
MLSS · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.43 | 0.35 | -0.19 | 1.25 |
| FCF Yield | -3.83% | -10.62% | -17.82% | -2.84% |
| EV / EBITDA | -10.97 | -6.76 | -2.93 | -17.47 |
| Quality | ||||
| ROIC | -109.30% | -84.52% | -84.04% | -43.92% |
| Gross Margin | 74.56% | 69.12% | 55.65% | 61.25% |
| Cash Conversion Ratio | 0.62 | 0.77 | 0.69 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.67% | -1.57% | 17.44% | 7.16% |
| Free Cash Flow Growth | 45.04% | 11.75% | -49.79% | 42.44% |
| Safety | ||||
| Net Debt / EBITDA | 0.43 | 0.37 | 0.94 | 1.94 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -451.01 |
| Efficiency | ||||
| Inventory Turnover | 0.59 | 1.15 | 2.18 | 2.59 |
| Cash Conversion Cycle | 467.65 | 196.60 | 18.11 | 66.80 |